Long term growth arrest of human Tenon's fibroblasts following single applications of β radiation

British Journal of Ophthalmology

Volumn 82, Issue 4, 1998, Pages 448-452

  Constable, P H ^a   Crowston, J G ^b   Occleston, N L ^b   Cordeiro, M F ^b   Khaw, P T ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MITOMYCIN C; PROTEIN P53; TRYPAN BLUE;

ARTICLE; BETA RADIATION; CELL CYCLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOLOGY; DNA SYNTHESIS; DOSE RESPONSE; FIBROBLAST; FIBROBLAST CULTURE; FILTERING OPERATION; GROWTH INHIBITION; HEALING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; SCAR FORMATION; TRABECULECTOMY;

EID: 0031967021     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.4.448     Document Type: Article

References (35)

1. The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the fluorouracil filtering surgery study. Am J Ophthalmol 1996;121:349-66.
2. Katz GJ, Higginbotham EJ, Lichter PR, et al. Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 1995;102:1263-9.
3. Skuta GL, Beeson CC, Higginbotham EJ, et al. Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 1992;99: 438-44.
4. Newhouse RP, Beyrer C. Hypotony as a late complication of trabeculectomy. Ann Ophthalmol 1982;July:685-6.
5. Jampel HD, Pasquale LR, Dibernardo C. Hypotony maculopathy following trabeculectomy with mitomycin C. Arch Ophthalmol 1992;110:1049-50.
6. Franks WA, Hitchings RA. Complications of 5-fluorouracil after trabeculectomy. Eye 1991;5:385-9.
7. Higginbotham EJ, Stevens RK, Musch DC, et al. Bleb-related endophthalmitis after trabeculectomy with mitomycin. Ophthalmology 1996;103:650-6.
8. Cooper JS. Postoperative irradiation of pterygia: ten more years of experience. Radiology 1978;28:753-6.
9. Aswad MI, Baum J. Optimal time for postoperative irradiation of pterygia. Ophthalmology 1987;94:1450-1.
10. Cameron M. Beta irradiation as an adjunct to surgery in refractory glaucoma. Trans Aust Coll Ophthalmol 1970;2: 53-60.
11. Cohen LB, Graham FT, Fry WE. Beta radiation as an adjunct to glaucoma surgery in the negro. Am J Ophthalmol 1959;47:54-61.
12. Iliff CE. Surgical control of glaucoma in the negro. Am J Ophthalmol 1944;27:731-8.
13. Miller MH, Rice NSC. Trabeculectomy combined with beta irradiation for congenital glaucoma. Br J Ophthalmol 1991; 75:584-90.
14. Nevarez JA, Parrish RK, Heuer DK, et al. The effect of beta irradiation on monkey Tenon's capsule fibroblasts in tissue culture. Curr Eye Res 1987;6:719-23.
15. Khaw PT, Ward S, Grierson I, et al. Effect of beta radiation on proliferating human Tenon's capsule fibroblasts. Br J Ophthalmol 1991;75:580-3.
16. Di Leonardo A, Linke SP, Clarkin K, et al. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 1994;8:2540-51.
17. Lane DP. p53 guardian of the genome. Nature 1992;358:15-16.
18. Chen PL, Chen Y, Bookstein R, et al. Genetic mechanisms of tumour suppression by the human p53 gene. Science 1990;250:1576-80.
19. Joseph JP, Grierson I, Hitchings RA. Normal rabbit aqueous humour, fibronectin and fibroblast conditioned medium are chemoattractant to Tenon's capsule fibroblasts. Eye 1987;1:585-92.
20. Khaw PT, Ward S, Porter A, et al. The long-term effects of 5-fluorouracil and sodium butyrate on human Tenon's fibroblasts. Invest Ophthalmol Vis Sci 1992;33:2043-52.
21. Tauchi H, Sawada S. Analysis of mitotic cell death caused by radiation in mouse leukaemia L5178Y cells: apoptosis is the ultimate form of cell death following mitotic failure. Int J Radiat Biol 1994;65:449-55.
22. Fuks Z, Persaud RS, Alfieri A, et al. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res 1994;2582-90.
23. Gratzner HG, Leif RC, Ingram DJ, et al. The use of antibody specific for bromodeoxyuridine for the immunofluorescent determination of DNA replication in single cells and chromosomes. Exp Cell Res 1975;95:88-94.
24. Stewart N, Hicks GG, Paraskevas F, et al. Evidence for a second cell cycle block at G2/M by p53. Oncogene 1995;10: 109-15.
25. Agarwal ML, Agarwal A, Taylor WR, et al. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 1995;92:8493-7.
26. Kuerbitz SJ, Plunkett BS, Walsh WV, et al. Wild-type p53 is a cell type checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992;89:7491-5.
27. Tobal K, Warren W, Cooper CS, et al. Increased expression and mutation of p53 in choroidal melanoma. Br J Cancer 1992;66:900-4.
28. Hooper ML. The role of the p53 and Rb-1 genes in cancer, development and apoptosis. J Cell Sci 1994;18:13-17.
29. Kastan MB, Zhan Q, El-Deiry W, et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992;71:587-97.
30. Enoch T, Norbury C. Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. TIBS 1995;20:426-30.
31. Lowe SW, Schmitt EM, Smith SW, et al. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993;362:847-9.
32. El- Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75: 817-25.
33. Dulic V, Kaufmann WK, Wilson SJ, et al. p53-dependent inhibition of cyclin- dependent kinase activities in human fibroblasts during radiation induced G1 arrest. Cell 1994;76:1013-23.
34. Occleston NL, Alexander RA, Mazure A, et al. Effects of single exposures to antiproliferative agents on ocular fibroblast mediated collagen contraction. Invest Ophthalmol Vis Sci 1994;35:3681-90.
35. Occleston NL, Daniels JT, Tarnuzzer RW, et al. Single exposures to antiproliferatives: long term effects on ocular fibroblast wound healing behaviour. Invest Ophthalmol Vis Sci 1997;(in press).